GL1X · GenesisL1 explorer

Research workbench

6HAX: Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB

Analyse 6HAX: Crystal structure of PROTAC 2 in complex with the bromodomain of human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6HAX
Type
protein
Length
927 residues
Chains
8
Method
x-ray diffraction
Authors
Roy, M., Bader, G., Diers, E., Trainor, N., Farnaby, W., Ciulli, A.
Deposited
08/09/18
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.35
Source
Homo sapiens
Molecule
Probable global transcription activator SNF2L2; von Hippel-Lindau disease tumor…
EC
3.6.4.-
UniProt
P51531, P40337, Q15369, Q15370
Ligands
FWZ
Pockets
9 · best druggability 0.67

Structure

x-ray diffraction · resolution 2.35 · 7 distinct chains · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable global transcription activator SNF2L2 (EC 3.6.4.-)protein11563% helix, 2% strandP51531
Bvon Hippel-Lindau disease tumor suppressorprotein14926% helix, 28% strandP40337
CElongin-Cprotein8843% helix, 15% strandQ15369
D, HElongin-Bprotein10421% helix, 38% strandQ15370
EProbable global transcription activator SNF2L2 (EC 3.6.4.-)protein12166% helix, 2% strandP51531
Fvon Hippel-Lindau disease tumor suppressorprotein14926% helix, 28% strandP40337
GElongin-Cprotein9740% helix, 13% strandQ15369

Ligands and binding sites

  • FWZ · (2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · 2 copies · chains A, B, E, F
  • EDO · 1,2-ethanediol · additive · 14 copies · chains A, B, C, D, E, F, G, H
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14900.670.7845EDO, FWZ
2630.660.9428empty
33740.640.7846EDO, FWZ
42540.550.7742empty
52650.510.7539empty

Interfaces

12 interfaces between chains.

  • C–D · 1153 Ų buried · 14 hydrogen bonds · protein-protein
  • G–H · 1142 Ų buried · 12 hydrogen bonds · protein-protein
  • F–G · 1142 Ų buried · 13 hydrogen bonds · protein-protein
  • B–C · 1095 Ų buried · 13 hydrogen bonds · protein-protein
  • B–F · 799 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 6HAX · Crystal structure of protac 2 in complex with the bromodomain of human SMARCA2 and… · the same entry in another collection · chain H against H, TM-score 1.00
  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain D against A, TM-score 0.99
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain C against A, TM-score 0.98

Analyse

Other records of 6HAX

  • 6HAX-2 · MolNFT v1 / PDB · Crystal structure of protac 2 in complex with the bromodomain of human SMARCA2 and…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.